Difference between revisions of "Haloperidol LA"
From Psychiatrienet
(non oral) |
|||
| (6 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Drug | {{Drug | ||
| name = Haloperidol | | name = Haloperidol | ||
| − | | name_link = | + | | name_link = Haloperidol_LA |
| addname = long acting | | addname = long acting | ||
| group = Butyrophenones | | group = Butyrophenones | ||
| type = Antipsychotic | | type = Antipsychotic | ||
| + | | ATC = N05AD01 | ||
| pubchem = 3559 | | pubchem = 3559 | ||
| + | | drugbank = APRD00538 | ||
| medscape = 6092 | | medscape = 6092 | ||
| medextra = - | | medextra = - | ||
| − | | | + | | drugscom = haloperidol |
| − | | ftk = | + | | ftk = haloperidol |
| − | | <includeonly> isswitch = 1 </includeonly> | + | | equivalent = 1 |
| + | | equivalent_ref = {{FTK-AP}} | ||
| + | | comparison = haloperidol | ||
| + | | halflife = 500 | ||
| + | | halflife_ref = <ref name="pts">{{pts|3791}}</ref> | ||
| + | | administration = IM | ||
| + | | DDD = 3.3 | ||
| + | | DDD_ref = <ref>{{WHOCC|N05AD01}}</ref> | ||
| + | | ctox = 20 | ||
| + | | ctox_ref = {{FTK-AP}} | ||
| + | | cth = 5 | ||
| + | | cth_ref = <ref name="pts" /> | ||
| + | | <includeonly> isswitch=1</includeonly> | ||
}} | }} | ||
| − | |||
Latest revision as of 19:09, 23 April 2010
| Haloperidol long acting | |||||||||||||||
| Type | Antipsychotic | ||||||||||||||
| Group | Butyrophenones | ||||||||||||||
| links | |||||||||||||||
| ATC-code | N05AD01 | ||||||||||||||
| Medscape | Haloperidol | ||||||||||||||
| PubChem | 3559 | ||||||||||||||
| PubMed | Haloperidol | ||||||||||||||
| Drugs.com | haloperidol | ||||||||||||||
| Kompas (Dutch) | Haloperidol | ||||||||||||||
| Wikipedia | Haloperidol | ||||||||||||||
| |||||||||||||||
Haloperidol (long acting) is a Antipsychotic in the group Butyrophenones.
